BR100 Increased By (1.02%)
BR30 Increased By (1.71%)
KSE100 Increased By (0.58%)
KSE30 Increased By (0.65%)
BECO 6.03 Increased By ▲ 0.26 (4.51%)
BML 52.61 Decreased By ▼ -0.39 (-0.74%)
BOP 34.23 Increased By ▲ 0.24 (0.71%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.23 Increased By ▲ 0.03 (0.25%)
FCCL 53.80 Increased By ▲ 0.97 (1.84%)
FCSC 5.24 Increased By ▲ 0.17 (3.35%)
FFL 18.03 Increased By ▲ 0.08 (0.45%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.07 Increased By ▲ 0.05 (0.62%)
KOSM 5.39 Decreased By ▼ -0.13 (-2.36%)
MLCF 87.90 Increased By ▲ 1.39 (1.61%)
NBP 186.60 Increased By ▲ 1.44 (0.78%)
PACE 10.75 Increased By ▲ 0.17 (1.61%)
PAEL 39.95 Increased By ▲ 0.53 (1.34%)
PIAHCLA 26.19 Decreased By ▼ -0.03 (-0.11%)
PIBTL 17.32 Increased By ▲ 0.65 (3.9%)
PPL 233.49 Increased By ▲ 5.31 (2.33%)
PRL 34.98 Increased By ▲ 0.30 (0.87%)
PTC 67.71 Increased By ▲ 2.38 (3.64%)
SEARL 90.90 Increased By ▲ 0.77 (0.85%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.57 Increased By ▲ 0.29 (3.5%)
THCCL 60.85 Increased By ▲ 2.35 (4.02%)
TPLP 8.78 Increased By ▲ 0.56 (6.81%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.01 Increased By ▲ 0.07 (0.7%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
Topic

COVAX vaccine

Iran says Iraq to release $125mn of frozen funds for vaccines

Iran says Iraq to release $125mn of frozen funds for vaccines

Published 29 May, 2021 05:54pm
  • Iran, the Middle Eastern country by COVID-19, has complained that US sanctions were preventing it from making payments to buy vaccines.
  • Ardakanian said the payments would go towards the purchase of vaccines from the World Health Organization (WHO) - sponsored global COVAX vaccine-sharing plan, state news agency IRNA reported.
WHO chief calls on vaccine makers to advance doses for COVAX

WHO chief calls on vaccine makers to advance doses for COVAX

Published 17 May, 2021 08:30pm
  • "While we appreciate the work of AstraZeneca who have been steadily increasing the speed and volume of their deliveries, we need other manufacturers to follow suit," said WHO Director-General Tedros Adhanom Ghebreyesus at a virtual briefing, mentioning Pfizer and Moderna specifically.
COVAX vaccines reach more than 100 countries, despite supply hits

COVAX vaccines reach more than 100 countries, despite supply hits

Published 08 Apr, 2021 07:19pm
  • Despite being hit by reduced supply availability in March and April, and higher demand in India where much of its main jab AstraZeneca is made, it expects to deliver doses to all economies that have requested them in the first half of 2021, the GAVI vaccine alliance and World Health Organization said.
COVAX vaccine-sharing scheme to send out 'hundreds of millions' of J&J shots

COVAX vaccine-sharing scheme to send out 'hundreds of millions' of J&J shots

Published 17 Mar, 2021 05:40pm
  • COVAX, backed by WHO and the Global Alliance for Vaccines and Immunization, aims to secure 2 billion vaccine doses by the end of 2021.
  • In early March, it said the target was to deliver 237 million doses of AstraZeneca's shot to 142 countries by the end of May, and it also shipped its first Pfizer shots.
Ghana kicks off coronavirus vaccination campaign with COVAX shots

Ghana kicks off coronavirus vaccination campaign with COVAX shots

Published 02 Mar, 2021 07:21pm
  • I feel so good about taking the vaccine. It will protect me from contracting the virus from patients.
  • COVAX aims to deliver over 1.3 billion vaccine doses to over 90 low- and middle-income countries by the end of the year, covering up to 20% of their populations.
J&J applies to WHO for emergency use listing of COVID-19 vaccine

J&J applies to WHO for emergency use listing of COVID-19 vaccine

Published 19 Feb, 2021 07:31pm
  • J&J said an emergency use listing is a prerequisite for supplying vaccines to the COVAX vaccine program, co-led by WHO, which aims to deliver doses to poor and middle-income countries.
  • The J&J vaccine is administered in a single dose and can be stored at normal fridge temperatures, a big selling point in countries with relatively weaker healthcare infrastructure.
COVAX following EMA, Britain, on ages for Astrazeneca vaccine

COVAX following EMA, Britain, on ages for Astrazeneca vaccine

Published 03 Feb, 2021 07:31pm
  • The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people.
  • The EMA has actually not restricted this vaccine in terms of age based upon the entire data packages, and of course that is a stringent regulatory authority.
GAVI seeks political support for COVAX as bilateral vaccine deals grow

GAVI seeks political support for COVAX as bilateral vaccine deals grow

Published 26 Jan, 2021 09:01pm
  • Our hope is this will lead to consensus to keep vast majority of work done through multilateral mechanisms and not bilateral. We have no ability to stop those bilateral mechanisms.
  • Covax has two price points for the Astrazeneca vaccine, $3 and $4 a dose, depending on the country, he said.
WHO, marking year since COVID-19 began, urges fair vaccine distribution to all

WHO, marking year since COVID-19 began, urges fair vaccine distribution to all

Updated 30 Dec, 2020 06:36pm
  • Tedros Adhanom Ghebreyesus, WHO director-general, appealed for $4 billion to buy COVID-19 vaccines for distribution in lower and middle-income countries.
  • Vaccines offer great hope to turn the tide of the pandemic. But to protect the world, we must ensure that all people at risk everywhere - not just in countries who can afford vaccines - are immunised.
Loading...